Cyclooxygenase-2 inhibition improves antioxidative defense during experimental hypercholesterolemia

Bosnian Journal of Basic Medical Sciences

Volumn 14, Issue 2, 2014, Pages 63-69

  Ahmed, Sagheer ^a,b   Gul, Saima ^a   Gul, Humera ^c   Zia Ul Haq, Muhammad ^d   Ercisli, Sezai ^e  

^a UNIVERSITI BRUNEI DARUSSALAM   (Brunei Darussalam)

^b KOHAT UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Pakistan)

^c ABDUL WALI KHAN UNIVERSITY   (Pakistan)

^d The Patent Office   (Pakistan)

^e ATATÜRK UNIVERSITY   (Turkey)

Author keywords

COX 2; GPX; Hypercholesterolemia; Inflammation; Oxidative stress; SOD; TAS

Indexed keywords

ANTIOXIDANT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; GLUTATHIONE PEROXIDASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NIMESULIDE; PYRAZOLE DERIVATIVE; SULFONAMIDE; SUPEROXIDE DISMUTASE;

ANIMAL; BLOOD; DISEASE MODEL; HYPERCHOLESTEROLEMIA; MALE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; RABBIT;

ANIMALS; ANTIOXIDANTS; CHOLESTEROL, LDL; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; GLUTATHIONE PEROXIDASE; HYPERCHOLESTEROLEMIA; MALE; OXIDATIVE STRESS; PYRAZOLES; RABBITS; SULFONAMIDES; SUPEROXIDE DISMUTASE;

EID: 84906688267     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2014.2264     Document Type: Article

References (29)

1. Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev. 2007; 65 (12 Pt 2):Si40-Si46.
2. Ondrejovičová I, Muchová J, Mišľanová C, Nagyová Z, Duračková Z. Hypercholesterolemia, oxidative stress and gender dependence in children. Prague Med Rep. 2010;11(4)300-312
3. Singh N, Dhalla AK, Seneviratne C, Singal PK. Oxidative stress and heart failure. Mol Cell Biochem. 1995; 147(1-2)77-81.
4. Liczmański AE. Oxygen toxicity, Part II. Defense mechanisms. Postepy Biochem. 1988; 34 (4): 293-310.
5. Zawadzka-Bartczak E. Activities of red blood cell anti-oxidative enzymes (SOD, GPx) and total anti-oxidative capacity of serum (TAS) in men with coronary atherosclerosis and in healthy pilots. Med Sci Monit. 2005; 11(9):CR440-444.
6. Vukelic N. Monitoring of total antioxidant status and activity of superoxide dismutase in patients with ischemic heart disease. Abstracts from MEDLAB, 12th IFCC European Congress of Clinical Chemistry, Basle. 1997; Poster A94.
7. Baines M, Shenkin A. Total antioxidant status of the patients receiving total parenteral nutrition (TNP). Proceed Nutr Soc. 1997; 56: Poster 242A.
8. Mitrevky A. Total antioxidant status and superoxide dismutase after cerebrovascular accident. XVI international Congress of Clinical Chemistry, London. 1996; Poster A106.
9. Domagała B, Dworski R. Lipid peroxides and antioxidants in plasma of healthy subjects and patients with atherosclerosis. Pol. Arch. Med. Wewn. 1986; 75: 327-30.
10. Salgo, MD. Plasma TAS in various diseases. Abstracts from the MEDLAB; 12th IFCC European Congress of Clinical Chemistry, Basle. 1997; Poster A11.
11. Maxwell SR. Anti-oxidant therapy: does it have a role in the treatment of human disease? Expert Opin Investig Drugs. 1997; 6(3):211-236.
12. Gavella M, Lipovac V, Vucić M, Rocić B. Superoxide scavenging capacity of human seminal plasma. Int J Androl. 1996; 19(2): 82-90.
13. Ukpanukpong, RU, Eteng, MU, Dasofunjo, K. Antioxidant interactions of Pefloxacin, garlic, vitamins C and E on lipid profile level of Albino wistar rats. J Applied Pharm Sci. 2013; 3 (3): 167-170.
14. Gul S, Ahmed S, Gul H, Kaneez KF. Investigating the protective effect of Solanum melongena. Asian J Health. 2011; 1(1)276-294.
15. Gul S, Ahmed S, Gul H, Shad KF, Zia-Ul-Haq M, Badiu D. The antioxidant potential of Brassica rapa L. on glutathione peroxidase, superoxide dismutase enzymes and total antioxidant status. Revista Română de Medicină de Laborator 2013; 21(2/4)161-169.
16. McEligot AJ, Yang S, Meyskens FL Jr. Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells. Annu Rev Nutr. 2005; 25:261-295.
17. Zawadzka-Bartczak E, Kopka L, Gancarz A. Antioxidative enzyme profiles in fighter pilots. Aviat Space Environ Med. 2003; 74:654-658.
18. Pérez Y, Menendez R, Ferrer JI, Lopez E, Castaño G, Fernández J, Ferreiro RM, Fernández L, Mendoza S, González R, and Mesa M. Effects of D-003, a mixture of high-molecular-weight sugar cane wax acids, on lipid peroxidation markers in older individuals: A randomized, double-blind, placebo-controlled study. Curr Ther Res Clin Exp. 2008; 69(1): 36-48.
19. Kerkeni M, Added F, Ben Farhat M, Miled A, Trivin F, Maaroufi K. yperhomocysteinaemia and parameters of antioxidative defence in Tunisian patients with coronary heart disease. Ann Clin Biochem. 2008; 45:193-198.
20. Dabhi JK, Solanki JK, Mehta A. Antiatherosclerotic activity of ibuprofen, a non-selective COX inhibitor-an animal study. Indian J Exp Biol. 2008;46(6):476-481.
21. Saeed SA, Ahmed S. Anti-ischemic effects of nimesulide, a cyclooxygenase-2 inhibitor on the ischemic model of rabbit induced by isoproterenol. Arch Pharma Res. 2006; 29(11)977-983.
22. Schrör K, Hohlfeld T. Inotropic actions of eicosanoids. Basic Res Cardiol. 1992; 87: 2-11.
23. Damron DS and Summers BA. Arachidonic acid enhances contraction and intracellular Ca2+ transients in individual rat ventricular myocytes. Am J Physiol. 1997; 272H350-H359.
24. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA. 1994; 91(25)12013-12017.
25. Goldhaber JI, Qayyum MS. Oxygen free radicals and excitationcontraction coupling. Antioxid Redox Signal. 2000; 2(1)55-64.
26. Agha AM, El-Khatib AS, Al-Zuhair H. Modulation of oxidant status by meloxicam in experimentally induced arthritis. Pharmacol Res. 1999; 40:385-392.
27. Chenevard R, Hürlimann D, Béchir M, Enseleit F, Spieker L, Hermann M. Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation. 2003; 107(3)405-409.
28. Saito T, Rodger IW, Hu F, Shennib H, Giaid A. Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction. Biochem Biophys Res Commun. 2000; 273(2)772-775.
29. Saeed SA, Ahmed S. Role of cyclooxygenase-2 in myocardial infarction and ischaemia. J Coll Physicians Surg Pak. 2006; 16(5): 324-328.